These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 7743473)

  • 1. Expression and mutation analysis of the p53 gene in uterine papillary serous carcinoma.
    King SA; Adas AA; LiVolsi VA; Takahashi H; Behbakht K; McGovern P; Benjamin I; Rubin SC; Boyd J
    Cancer; 1995 Jun; 75(11):2700-5. PubMed ID: 7743473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uterine papillary serous carcinoma evolves via a p53-driven pathway.
    Moll UM; Chalas E; Auguste M; Meaney D; Chumas J
    Hum Pathol; 1996 Dec; 27(12):1295-300. PubMed ID: 8958301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of p53 function in uterine papillary serous carcinoma.
    Kovalev S; Marchenko ND; Gugliotta BG; Chalas E; Chumas J; Moll UM
    Hum Pathol; 1998 Jun; 29(6):613-9. PubMed ID: 9635683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p53 and bcl-2 expression in invasive and pre-invasive uterine papillary serous carcinoma and atrophic endometrium.
    Busmanis I; Ho TH; Tan SB; Khoo KS
    Ann Acad Med Singap; 2005 Aug; 34(7):421-5. PubMed ID: 16123814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p53 protein overexpression: a strong prognostic factor in uterine papillary serous carcinoma.
    Bancher-Todesca D; Gitsch G; Williams KE; Kohlberger P; Neunteufel W; Obermair A; Heinze G; Breitenecker G; Hacker NF
    Gynecol Oncol; 1998 Oct; 71(1):59-63. PubMed ID: 9784320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p27 and cyclin D1 abnormalities in uterine papillary serous carcinoma.
    Schmitz MJ; Hendricks DT; Farley J; Taylor RR; Geradts J; Rose GS; Birrer MJ
    Gynecol Oncol; 2000 Jun; 77(3):439-45. PubMed ID: 10831356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endometrial glandular dysplasia: a newly defined precursor lesion of uterine papillary serous carcinoma. Part I: morphologic features.
    Zheng W; Liang SX; Yu H; Rutherford T; Chambers SK; Schwartz PE
    Int J Surg Pathol; 2004 Jul; 12(3):207-23. PubMed ID: 15306933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased expression of 14-3-3σ is predictive of poor prognosis for patients with human uterine papillary serous carcinoma.
    Suzuki F; Nagase S; Suzuki K; Oba E; Hiroki E; Matsuda Y; Akahira J; Nishigori H; Sugiyama T; Otsuki T; Yoshinaga K; Takano T; Niikura H; Ito K; Sasano H; Yaegashi N
    Tohoku J Exp Med; 2013 Nov; 231(3):193-9. PubMed ID: 24201220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uterine papillary serous adenocarcinoma. A 10-case study of p53 and c-erbB-2 expression and DNA content.
    Prat J; Oliva E; Lerma E; Vaquero M; Matías-Guiu X
    Cancer; 1994 Sep; 74(6):1778-83. PubMed ID: 7915964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53 overexpression and bcl-2 persistence in endometrial carcinoma: comparison of papillary serous and endometrioid subtypes.
    Zheng W; Cao P; Zheng M; Kramer EE; Godwin TA
    Gynecol Oncol; 1996 May; 61(2):167-74. PubMed ID: 8626128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endometrial carcinoma: the prognostic impact of papillary serous carcinoma (UPSC) in relation to nuclear grade, DNA ploidy and p53 expression.
    Nordström B; Strang P; Lindgren A; Bergström R; Tribukait B
    Anticancer Res; 1996; 16(2):899-904. PubMed ID: 8687148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Papillary serous carcinoma of the peritoneum: analysis of clonality of peritoneal tumors.
    Nishimura- M; Wakabayashi M; Hashimoto T; Shibata J; Ueyama H; Ebina M; Fujiyama Y; Bamba T
    J Gastroenterol; 2000; 35(7):540-7. PubMed ID: 10905363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishment and characterization of two cell lines (HEC-155, HEC-180) derived from uterine papillary serous adenocarcinoma.
    Iida T; Hamano M; Yoshida N; Yonamine K; Hayashi K; Kiguchi K; Ishizuka B; Nishimura Y; Arai T; Kawaguchi M; Hata H; Watanabe J; Kuramoto H
    Eur J Gynaecol Oncol; 2004; 25(4):423-7. PubMed ID: 15285295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p53 nuclear protein accumulation correlates with mutations in the p53 gene, tumor grade, and stage in bladder cancer.
    Esrig D; Spruck CH; Nichols PW; Chaiwun B; Steven K; Groshen S; Chen SC; Skinner DG; Jones PA; Cote RJ
    Am J Pathol; 1993 Nov; 143(5):1389-97. PubMed ID: 7901994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequent occurrence of p53 gene mutations in uterine cancers at advanced clinical stage and with aggressive histological phenotypes.
    Tsuda H; Hirohashi S
    Jpn J Cancer Res; 1992 Nov; 83(11):1184-91. PubMed ID: 1336492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MDM2 and p53 protein expression in the histologic subtypes of endometrial carcinoma.
    Ambros RA; Sheehan CE; Kallakury BV; Ross JS; Malfetano J; Paunovich E; Figge J
    Mod Pathol; 1996 Dec; 9(12):1165-9. PubMed ID: 8972476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Her-2/neu overexpression and amplification in uterine papillary serous carcinoma.
    Slomovitz BM; Broaddus RR; Burke TW; Sneige N; Soliman PT; Wu W; Sun CC; Munsell MF; Gershenson DM; Lu KH
    J Clin Oncol; 2004 Aug; 22(15):3126-32. PubMed ID: 15284264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. WT1 immunoreactivity in uterine papillary serous carcinomas is different from ovarian serous carcinomas.
    Goldstein NS; Uzieblo A
    Am J Clin Pathol; 2002 Apr; 117(4):541-5. PubMed ID: 11939727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular pathology of primary and metastatic ductal pancreatic lesions: analyses of mutations and expression of the p53, mdm-2, and p21/WAF-1 genes in sporadic and familial lesions.
    Ruggeri BA; Huang L; Berger D; Chang H; Klein-Szanto AJ; Goodrow T; Wood M; Obara T; Heath CW; Lynch H
    Cancer; 1997 Feb; 79(4):700-16. PubMed ID: 9024708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical significance of Her-2/neu status in patients with uterine papillary serous carcinoma].
    Ren YL; Wang HY; Zhou XY; Shan BE; Yang WT; Shen L; Shi DR
    Zhonghua Fu Chan Ke Za Zhi; 2010 May; 45(5):367-71. PubMed ID: 20646447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.